Amalgamated Bank Anavex Life Sciences Corp. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Amalgamated Bank holds 2,310 shares of AVXL stock, worth $24,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,310
Previous 2,310 -0.0%
Holding current value
$24,231
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$4.55 - $6.75 $34,457 - $51,117
-7,573 Reduced 76.63%
2,310 $12,000
Q4 2023

Feb 06, 2024
SELL
$5.04 - $9.95 $3,462 - $6,835
-687 Reduced 6.5%
9,883 $92,000
Q2 2023

Aug 11, 2023
BUY
$7.66 - $9.5 $7,958 - $9,870
1,039 Added 10.9%
10,570 $85,000
Q1 2023

May 02, 2023
SELL
$8.32 - $11.75 $12,064 - $17,037
-1,450 Reduced 13.2%
9,531 $82,000
Q3 2022

Nov 09, 2022
BUY
$8.9 - $12.86 $2,465 - $3,562
277 Added 2.59%
10,981 $113,000
Q2 2022

Aug 15, 2022
SELL
$7.31 - $12.84 $1,600 - $2,811
-219 Reduced 2.0%
10,704 $107,000
Q1 2022

Jun 30, 2022
SELL
$9.74 - $17.69 $7,305 - $13,267
-750 Reduced 6.43%
10,923 $134,000
Q4 2021

Feb 15, 2022
BUY
$16.88 - $23.31 $4,017 - $5,547
238 Added 2.08%
11,673 $202,000
Q3 2021

Oct 29, 2021
SELL
$16.82 - $25.75 $4,760 - $7,287
-283 Reduced 2.42%
11,435 $205,000
Q2 2021

Aug 16, 2021
BUY
$10.16 - $28.86 $119,054 - $338,181
11,718 New
11,718 $268,000

Others Institutions Holding AVXL

# of Institutions
161
Shares Held
27.4M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $818M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email